Sigma Planning Corp
LBRX icon

Sigma Planning Corp’s LB Pharmaceuticals LBRX Stock Holding History

Sigma Planning Corp’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.15M Buy
+30,000
New +$1.24M 0.03% 532

Other funds holding LBRX

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Sigma Planning Corp's LBRX Position: Q3 2026 in Review

Sigma Planning Corp opened a new position in LB Pharmaceuticals (LBRX) in Q3 2026: 30,000 shares worth $1.15M. The stake represents 0.03% of the portfolio and ranks #532 among its holdings.

8 funds tracked by Wall St. Rank hold LBRX as of Q3 2026.

  • Sigma Planning Corp held 30,000 shares of LB Pharmaceuticals worth $1.15M as of Q3 2026.
  • LB Pharmaceuticals was a new Sigma Planning Corp position in Q3 2026.
  • LB Pharmaceuticals made up 0.03% of Sigma Planning Corp's portfolio in Q3 2026, its #532 holding.
  • 8 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q3 2026.

Based on Sigma Planning Corp's 13F filing for Q3 2026, filed 23 Oct 2026.